Health & Fitness

According to FutureWise analysis, the market for cell-based assays in 2025 is US$19.8 billion, and is expected to reach US$37.93 billion by 2033 at a CAGR of 8.60%. The Cell-Based Assay Market landscape is diverse, encompassing various end-users, including academic and government institutions, contract research organizations (CROs), and pharmaceutical and biotechnology companies. Currently, pharmaceutical and biotechnology companies dominate the market share, a trend expected to persist throughout the forecast period. Notably, the CRO segment is anticipated to experience significant growth, driven by an increasing trend of pharmaceutical companies outsourcing their drug discovery activities. The drug discovery segment is poised to further enhance market expansion, driven by increasing investments in research and development from pharmaceutical companies. Additionally, the growing prevalence of diabetes and cardiovascular diseases is creating a favorable environment for ... Continue reading →

According to FutureWise analysis, the market for cell counting in 2023 is US$8.81 billion, and is expected to reach US$16.83 billion by 2031 at a CAGR of 8.4%. Cell counting is more than just a simple numerical task; it's a vital process that plays a crucial role in the world of biology and medicine. This technique enables researchers and clinicians to determine the number of cells present in a sample, providing insights into cell concentration and viability. Imagine peering into a microscope, manually counting cells one by one, or relying on advanced automated systems that can swiftly and accurately tally them for you. Then there’s flow cytometry – a cutting-edge method that not only counts cells at lightning speed but also unveils essential details about their properties through fluorescence and light scattering. But why is cell counting so important? It has a wide array of applications that touch nearly every aspect of scientific exploration. In research, for ... Continue reading →

According to FutureWise analysis, the market for cell culture incubators in 2023 is US$2.31 billion, and is expected to reach US$3.86 billion by 2031 at a CAGR of 6.60%. The global Cell Culture Incubator Market was valued at approximately USD 2.31 billion in 2023 and is projected to experience significant growth, reaching an estimated USD 3.86 billion by 2031. This growth represents a compound annual growth rate (CAGR) of 6.6% throughout the forecast period. Several factors contribute to this steady expansion, notably the increasing demand for cell culture applications across various sectors, including pharmaceuticals, biomedical research, clinical diagnostics, and in vitro fertilization (IVF) procedures. As the biopharmaceutical industry continues to thrive and innovations in cell therapy and regenerative medicine develop, the need for reliable and precise incubation solutions is becoming more critical. Technological advancements in incubator designs are also playing a vital role in ... Continue reading →

According to FutureWise analysis, the market for cell culture media in 2023 is US$4.58 billion, and is expected to reach US$11.7 billion by 2031 at a CAGR of 12.50%. Cell culture medium is a nutrient-rich substance essential for the growth and survival of cells and microorganisms under specific incubation conditions. It is designed to support cell growth by providing a source of energy and helping to regulate the cell cycle of cells developing in vitro. A basic cell culture mixture typically includes vitamins, amino acids, glucose, growth hormones, and inorganic ions. Additionally, the medium helps maintain the pH and osmolarity of the cultivated cells.The composition of this medium consists of amino acids, inorganic salts, vitamins, serum, glucose, and other critical nutrients necessary for cell growth. Cell culture mediums are used in various applications, including toxicity testing, genetic engineering, stem cell research, tissue engineering, biochemistry, cancer research, and drug ... Continue reading →

According to FutureWise analysis, the market for Cell Cycle Analysis in 2023 is US$3.22 billion, and is expected to reach US$5.62 billion by 2031 at a CAGR of 7.20%. The global Cell Cycle Analysis Market was valued at approximately USD 20.20 billion in 2023 and is anticipated to grow significantly, reaching nearly USD 51.34 billion by 2032. This growth represents a robust compound annual growth rate (CAGR) of 10.98% from 2024 to 2032. Several key factors are fueling this expansion, including intensified efforts in drug discovery and development, the rising incidence of chronic diseases, particularly cancer, and continuous technological advancements in the field. The market is primarily driven by innovations in methodologies such as flow cytometry and high-throughput/high-content screening, which enhance the efficiency and precision of cell cycle analysis. Additionally, the integration of artificial intelligence (AI) in these processes is facilitating faster data analysis and ... Continue reading →

According to FutureWise analysis, the market for clinical chemistry analyzers in 2023 is US$13 billion, and is expected to reach US$19.38 billion by 2031 at a CAGR of 5.10%. The global Clinical Chemistry Analyzers Market is experiencing significant growth, currently valued at approximately USD 18.63 billion in 2023 and anticipated to expand to around USD 25.88 billion by 2030. This represents a robust compound annual growth rate (CAGR) of roughly 4.8% from 2024 to 2030. The market’s expansion is primarily driven by the rising demand for routine biochemical testing, particularly as chronic and non-communicable diseases—such as diabetes, cardiovascular conditions, and metabolic syndromes—become increasingly prevalent worldwide. Key drivers fueling this growth include remarkable advancements in technology, such as automation and miniaturization, which have enhanced the efficiency and accuracy of testing procedures. Innovations in point-of-care testing capabilities ... Continue reading →

According to FutureWise's analysis, the market for Clinical Information Systems is expected to reach US$2.06 billion by 2031, growing at a CAGR of 8.20%. The global Clinical Information System (CIS) Market was valued at approximately USD 1,117.6 million in 2023 and is projected to experience substantial growth, reaching around USD 2,412.8 million by 2034. This remarkable expansion represents a compound annual growth rate (CAGR) of about 8.0% from 2024 to 2034. Several factors are driving this growth, including a heightened demand for real-time access to comprehensive patient data, which is crucial for informed clinical decision-making. Additionally, regulatory incentives are increasingly favoring the adoption of digital healthcare workflows, propelling healthcare providers toward modernization. Innovative technologies, such as cloud deployment, advanced AI-enhanced analytics, and improved interoperability among systems—specifically Electronic Health Records (EHRs), ... Continue reading →

According to FutureWise's analysis, the Clinical Laboratory Services market is projected to grow at a CAGR of 5.40% from 2025 to 2033.  The Clinical Laboratory Services market is on a promising upward trajectory! This growth is fueled by a surge in demand for early disease detection and personalized medicine, alongside the increasing prevalence of chronic illnesses. Innovations in diagnostic technologies, such as molecular diagnostics and automation, are revolutionizing laboratory efficiency and precision. Moreover, the rise of telehealth and home testing kits is breaking down barriers, making lab services more accessible, particularly in remote and underserved areas. Exciting strategic partnerships and acquisitions are also reshaping the competitive landscape, bringing fresh dynamics to the industry. Clinical lab services are essential to modern healthcare, providing a wide array of applications centered around detecting and measuring various biological substances. The ... Continue reading →

According to FutureWise analysis, the market for Clinical Microbiology is expected to reach US$4.80 billion by 2031 at a CAGR of 6.70%. Clinical microbiology is a vital branch of medical science that plays a crucial role in combating infectious diseases. It’s all about uncovering the hidden agents behind illnesses, whether they be bacteria, viruses, fungi, or parasites. By utilizing a wide array of testing techniques, including direct smears and cultures, as well as cutting-edge molecular analysis and serological testing, clinicians can effectively pinpoint the presence of these microorganisms and determine their susceptibility to various treatments. As the global demand for effective antibiotic use and improved therapeutic outcomes rises, clinical microbiology is rapidly gaining prominence. This field involves the meticulous collection and analysis of clinical specimens, enabling the identification and characterization of infectious agents while working closely with healthcare ... Continue reading →

According to FutureWise analysis, the market for clinical nutrition in 2023 is US$13.4 billion, and is expected to reach US$23.76 billion by 2031 at a CAGR of 7.40%. The global Clinical Nutrition Market was valued at approximately USD 13.4 billion in 2023 and is forecasted to experience substantial growth, nearly doubling to an impressive USD 29.2 billion by 2033. This exponential growth reflects a robust compound annual growth rate (CAGR) of around 8.1% over the next decade. The market's expansion is primarily fueled by the increasing prevalence of chronic health conditions such as diabetes, cancer, and malnutrition, alongside a growing aging population. Additionally, there is a rising number of premature infants requiring specialized nutritional support, and an increasing demand for clinical nutrition in various settings, including hospitals, home healthcare, and geriatric care. In terms of market segments, oral and enteral nutrition products stand out, dominating the industry ... Continue reading →